Obstet Gynecol Sci.  2013 May;56(3):135-136.

Should advanced maternal age be a reasonable indication for invasive diagnostic testing?

• Ryu HM

Abstract

No abstract available.

MeSH Terms

Maternal Age

Reference

1. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007. 109:217–227.

2. Forabosco A, Percesepe A, Santucci S. Incidence of non-age-dependent chromosomal abnormalities: a population-based study on 88965 amniocenteses. Eur J Hum Genet. 2009. 17:897–903.

3. Boyd PA, Loane M, Garne E, Khoshnood B, Dolk H. EUROCAT working group. Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy. Eur J Hum Genet. 2011. 19:231–234.

4. Kwon JY, Park IY, Kwon SM, Kim CJ, Shin JC. The quadruple test for Down syndrome screening in pregnant women of advanced maternal age. Arch Gynecol Obstet. 2012. 285:629–633.

5. Park IY, Kwon JY, Kim YH, Kim M, Shin JC. Maternal age-specific rates of fetal chromosomal abnormalities at 16-20 weeks' gestation in Korean pregnant women >or=35 years of age. Fetal Diagn Ther. 2010. 27:214–221.

6. Bornstein E, Lenchner E, Donnenfeld A, Barnhard Y, Seubert D, Divon MY. Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice. J Perinat Med. 2009. 37:99–102.

7. Henry GP, Britt DW, Evans MI. Screening advances and diagnostic choice: the problem of residual risk. Fetal Diagn Ther. 2008. 23:308–315.